Evidence map›Paper›PMID 31686052›Full record

ArticleNature structural & molecular biology2019

Multiple direct interactions of TBP with the MYC oncoprotein.

Yong Wei, Diana Resetca, Zhe Li, Isak Johansson-Åkhe, Alexandra Ahlner, Sara Helander, Amelie Wallenhammar, Vivian Morad, Brian Raught, Björn Wallner and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature structural & molecular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Targeting MYC-Driven Cancers: From Oncogenic Addiction to Therapeutic Vulnerability.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Harnessing the TAF1 Acetyltransferase for Targeted Acetylation of the Tumor Suppressor p53.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Manipulating Myc for reparative regeneration.Frontiers in cell and developmental biology · 2024
    Review
  17. Review
  18. Article
  19. MYC: a complex problem.Trends in cell biology · 2023
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Yong Wei *Department of Physics, Chemistry, and Biology, Linköping University, Linköping, Sweden.ORCID http://orcid.org/0000-0002-3314-118X
Diana Resetca *Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Zhe LiMolecular and Cellular Biology Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.
Isak Johansson-ÅkheDepartment of Physics, Chemistry, and Biology, Linköping University, Linköping, Sweden.
Alexandra AhlnerDepartment of Physics, Chemistry, and Biology, Linköping University, Linköping, Sweden.
Sara HelanderDepartment of Physics, Chemistry, and Biology, Linköping University, Linköping, Sweden.
Amelie WallenhammarDepartment of Physics, Chemistry, and Biology, Linköping University, Linköping, Sweden.
Vivian MoradDepartment of Physics, Chemistry, and Biology, Linköping University, Linköping, Sweden.
Brian RaughtPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Björn WallnerDepartment of Physics, Chemistry, and Biology, Linköping University, Linköping, Sweden.
Tetsuro KokuboMolecular and Cellular Biology Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Kanagawa, Japan.
Yufeng TongStructural Genomics Consortium, Toronto, Ontario, Canada.
Linda Z PennPrincess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Linda.Penn@uhnresearch.ca.
Maria SunnerhagenDepartment of Physics, Chemistry, and Biology, Linköping University, Linköping, Sweden. maria.sunnerhagen@liu.se.ORCID http://orcid.org/0000-0002-0492-5890
Linköping University · SEUniversity Health Network · CAYokohama City University · JPStructural Genomics Consortium · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcription factor c-MYC is a potent oncoprotein; however, the mechanism of transcriptional regulation via MYC-protein interactions remains poorly understood. The TATA-binding protein (TBP) is an essential component of the transcription initiation complex TFIID and is required for gene expression. We identify two discrete regions mediating MYC-TBP interactions using structural, biochemical and cellular approaches. A 2.4 -Å resolution crystal structure reveals that human MYC amino acids 98-111 interact with TBP in the presence of the amino-terminal domain 1 of TBP-associated factor 1 (TAF1

Indexed as

Protein Interaction MapsCell Line, TumorCrystallography, X-RayHistone AcetyltransferasesHumansModels, MolecularProtein ConformationProtein Interaction Domains and MotifsProto-Oncogene Proteins c-mycTATA-Binding Protein Associated FactorsTATA-Box Binding ProteinTranscription Factor TFIIDHistone AcetyltransferasesMYC protein, humanProto-Oncogene Proteins c-mycTATA-binding protein associated factor 250 kDaTATA-Binding Protein Associated FactorsTATA-Box Binding ProteinTranscription Factor TFIID

Identifiers

PMID31686052
OpenAlexW2989339993

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.